A Global Injection Safety campaign was announced in Geneva on the 23rd and 24th February 2015, by DG – Dr Margaret Chan. This policy will aim to reduce unnecessary injections worldwide and ensure that only AD (Auto Disable)/RUP (Reuse Prevention) syringes are used for the therapeutic (curative) sector.
The policy highlights the need for global donors, manufacturers and MOH to work together and confirms data from a cost effectiveness analysis will make enormous savings:
For every dollar invested an average of $14.57 could be saved from reduced costs in treatment of HIV, HBV and HCV.
L: Marc Koska, OBE & WHO DG Dr. Margaret Chan, R: Geneva Convention delegates
